LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

LeMaitre Vascular, Inc.

Activ Surgical is involved in the development of surgical technologies and tools. Self-described as innovative, it focuses on enhancing surgical procedures through its technological offerings.

Activ Surgical

QuidelOrtho provides diagnostic solutions and products aimed at enhancing healthcare through testing capabilities in both at-home and clinical settings. Self-described as offering solutions across the healthcare continuum.

QuidelOrtho

LeMaitre Vascular provides vascular surgery solutions, self-described as game-changing since 1983.

Metric
Company Name	LeMaitre Vascular, Inc.	Activ Surgical	QuidelOrtho
Symbol	LMAT
MSH ID	COM:LEMAITRE	COM:ACTIVSURGICAL	COM:QUIDEL
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices	Medical Devices and Diagnostics
Country	US	US	US
Stage
Employee Count	614
Website	lemaitre.com	activsurgical.com	quidel.com
LinkedIn
Founders

Metric
Market Cap	1.87B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	193.48M
Revenue (LTM)
Revenue (NTM)
Gross Profit	120.96M
EBITDA	46.60M
Operating Income	37.08M
Net Income	30.11M
EPS	1.36
Diluted EPS	1.34
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.67
Operating Profit Margin	0.22
EBITDA Margin	0.24
Net Profit Margin	0.18
Return on Equity	0.12
Return on Assets	0.10
Return on Capital Employed	0.14

COM:LEMAITRE

LeMaitre Vascular

Last Close

105.87

22/11 21:00

Market Cap

1.87B

Beta: -

Volume Today

128.58K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	47.66
P/B Ratio	4.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	10.18
EV Multiple	44.55

Metric
Days Sales Outstanding	46.98
Days Payables Outstanding	24.28
Days Inventory Outstanding	342.30
Operating Cycle	397.01
Cash Conversion Cycle	386.29
Asset Turnover	0.57

Metric
Operating Cash Flow	36.75M
Free Cash Flow	29.49M
Cash Flow to Debt	15.26
Operating Cash Flow/Sales	0.20
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	24.27M
Accounts Receivable	-3.13M
Inventory	52.33M
Goodwill	65.94M
Debt to Capitalization	0.06
Debt to Assets	0.05
Current Ratio	6.28
Quick Ratio	5.86

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue	0.09
SG&A to Revenue	0.16